The trans-cleavage activity of CRISPR/Cas12a
has
been widely used in biosensing. However, many CRISPR/Cas12a-based
biosensors, especially those that work in “on–off–on”
mode, usually suffer from high background and thus impossible intracellular
application. Herein, this problem is efficiently overcome by elaborately
designing the activator strand (AS) of CRISPR/Cas12a using the “RESET”
effect found by our group. The activation ability of the as-designed
AS to CRISPR/Cas12a can be easily inhibited, thus assuring a low background
for subsequent biosensing applications, which not only benefits the
detection sensitivity improvement of CRISPR/Cas12a-based biosensors
but also promotes their applications in live cells as well as makes
it possible to design high-performance biosensors with greatly improved
flexibility, thus achieving the analysis of a wide range of targets.
As examples, by using different strategies such as strand displacement,
strand cleavage, and aptamer–substrate interaction to reactivate
the inhibited enzyme activity, several CRISPR/Cas12a-based biosensing
systems are developed for the sensitive and specific detection of
different targets, including nucleic acid (miR-21), biological small
molecules (ATP), and enzymes (hOGG1), giving the detection limits
of 0.96 pM, 8.6 μM, and 8.3 × 10–5 U/mL,
respectively. Thanks to the low background, these biosensors are demonstrated
to work well for the accurate imaging analysis of different biomolecules
in live cells. Moreover, we also demonstrate that these sensing systems
can be easily combined with lateral flow assay (LFA), thus holding
great potential in point-of-care testing, especially in poorly equipped
or nonlaboratory environments.